Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

1.

Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies.

Cesano A, Perbellini O, Evensen E, Chu CC, Cioffi F, Ptacek J, Damle RN, Chignola R, Cordeiro J, Yan XJ, Hawtin RE, Nichele I, Ware JR, Cavallini C, Lovato O, Zanotti R, Rai KR, Chiorazzi N, Pizzolo G, Scupoli MT.

Haematologica. 2013 Apr;98(4):626-34. doi: 10.3324/haematol.2012.071910. Epub 2012 Nov 9.

PMID:
23144194
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.

Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S, Leone G, Efremov DG.

Blood. 2005 Jun 15;105(12):4820-7. Epub 2005 Feb 22.

PMID:
15728130
[PubMed - indexed for MEDLINE]
Free Article
3.

Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.

Blix ES, Irish JM, Husebekk A, Delabie J, Forfang L, Tierens AM, Myklebust JH, Kolstad A.

BMC Cancer. 2012 Oct 16;12:478. doi: 10.1186/1471-2407-12-478.

PMID:
23072591
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.

Palomba ML, Piersanti K, Ziegler CG, Decker H, Cotari JW, Bantilan K, Rijo I, Gardner JR, Heaney M, Bemis D, Balderas R, Malek SN, Seymour E, Zelenetz AD, van den Brink MR, Altan-Bonnet G.

PLoS One. 2014 Jan 29;9(1):e79987. doi: 10.1371/journal.pone.0079987. eCollection 2014.

PMID:
24489640
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.

Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F, Packham G.

Blood. 2003 Feb 1;101(3):1087-93. Epub 2002 Sep 26.

PMID:
12393552
[PubMed - indexed for MEDLINE]
Free Article
6.

High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.

Herling M, Patel KA, Weit N, Lilienthal N, Hallek M, Keating MJ, Jones D.

Blood. 2009 Nov 19;114(21):4675-86. doi: 10.1182/blood-2009-03-208256. Epub 2009 Sep 21.

PMID:
19770358
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival.

Wang YH, Fan L, Wang L, Zhang R, Zou ZJ, Fang C, Zhang LN, Li JY, Xu W.

Leuk Lymphoma. 2013 Jun;54(6):1165-70. doi: 10.3109/10428194.2012.736983. Epub 2012 Nov 2.

PMID:
23039362
[PubMed - indexed for MEDLINE]
8.

B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.

Nédellec S, Renaudineau Y, Bordron A, Berthou C, Porakishvili N, Lydyard PM, Pers JO, Youinou P.

J Immunol. 2005 Mar 15;174(6):3749-56.

PMID:
15749915
[PubMed - indexed for MEDLINE]
Free Article
9.

Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells.

Palazzo AL, Evensen E, Huang YW, Cesano A, Nolan GP, Fantl WJ.

PLoS One. 2011;6(10):e24592. doi: 10.1371/journal.pone.0024592. Epub 2011 Oct 10.

PMID:
22016760
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.

Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, Raghavachari N, Liu P, McCoy JP, Raffeld M, Stetler-Stevenson M, Yuan C, Sherry R, Arthur DC, Maric I, White T, Marti GE, Munson P, Wilson WH, Wiestner A.

Blood. 2011 Jan 13;117(2):563-74. doi: 10.1182/blood-2010-05-284984. Epub 2010 Oct 12.

PMID:
20940416
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.

Gobessi S, Laurenti L, Longo PG, Carsetti L, Berno V, Sica S, Leone G, Efremov DG.

Leukemia. 2009 Apr;23(4):686-97. doi: 10.1038/leu.2008.346. Epub 2008 Dec 18.

PMID:
19092849
[PubMed - indexed for MEDLINE]
12.

Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.

Johansson P, Eisele L, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J, Nückel H.

Leuk Res. 2010 Jul;34(7):892-8. doi: 10.1016/j.leukres.2010.02.038. Epub 2010 Mar 29.

PMID:
20353875
[PubMed - indexed for MEDLINE]
13.

CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.

Sivina M, Hartmann E, Kipps TJ, Rassenti L, Krupnik D, Lerner S, LaPushin R, Xiao L, Huang X, Werner L, Neuberg D, Kantarjian H, O'Brien S, Wierda WG, Keating MJ, Rosenwald A, Burger JA.

Blood. 2011 Feb 3;117(5):1662-9. doi: 10.1182/blood-2010-09-307249. Epub 2010 Nov 29.

PMID:
21115978
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

Quiroga MP, Balakrishnan K, Kurtova AV, Sivina M, Keating MJ, Wierda WG, Gandhi V, Burger JA.

Blood. 2009 Jul 30;114(5):1029-37. doi: 10.1182/blood-2009-03-212837. Epub 2009 Jun 2.

PMID:
19491390
[PubMed - indexed for MEDLINE]
Free Article
15.

Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.

Buchner M, Baer C, Prinz G, Dierks C, Burger M, Zenz T, Stilgenbauer S, Jumaa H, Veelken H, Zirlik K.

Blood. 2010 Jun 3;115(22):4497-506. doi: 10.1182/blood-2009-07-233692. Epub 2010 Mar 24.

PMID:
20335218
[PubMed - indexed for MEDLINE]
Free Article
16.

Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia.

Kawauchi K, Ogasawara T, Yasuyama M.

Int J Hematol. 2002 Jun;75(5):508-13.

PMID:
12095152
[PubMed - indexed for MEDLINE]
17.

The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia.

Le Roy C, Deglesne PA, Chevallier N, Beitar T, Eclache V, Quettier M, Boubaya M, Letestu R, Lévy V, Ajchenbaum-Cymbalista F, Varin-Blank N.

Blood. 2012 Jul 12;120(2):356-65. doi: 10.1182/blood-2011-12-397158. Epub 2012 May 21.

PMID:
22613791
[PubMed - indexed for MEDLINE]
Free Article
18.

Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.

Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D.

Blood. 1996 Dec 1;88(11):4259-64.

PMID:
8943862
[PubMed - indexed for MEDLINE]
Free Article
19.

CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study.

Del Poeta G, Del Principe MI, Zucchetto A, Luciano F, Buccisano F, Rossi FM, Bruno A, Biagi A, Bulian P, Maurillo L, Neri B, Bomben R, Simotti C, Coletta AM, Dal Bo M, de Fabritiis P, Venditti A, Gattei V, Amadori S.

Haematologica. 2012 Feb;97(2):279-87. doi: 10.3324/haematol.2011.052829. Epub 2011 Oct 11.

PMID:
21993667
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia.

Molica S, Digiesi G, Mirabelli R, Cutrona G, Antenucci A, Molica M, Giannarelli D, Sperduti I, Morabito F, Neri A, Baldini L, Ferrarini M.

Eur J Haematol. 2009 Sep;83(3):208-14. doi: 10.1111/j.1600-0609.2009.01273.x. Epub 2009 May 2.

PMID:
19459926
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk